Table 2.
Treatment Group | Group A RS < 11 NHT N = 12 |
Group B RS = 11–25 NHT N = 18 |
Group C RS = 11–25 NCT N = 11 |
Group D RS ≥ 26 NCT N = 14 |
Overall P value |
---|---|---|---|---|---|
cCR | 8.3% | 22.2% | 36.4% | 28.6% | 0.0422 |
cPR | 75.0% | 27.8% | 36.4% | 64.3% | |
cCR + cPR | 83.3% | 50.0% | 72.7% | 92.9% | 0.0490 |
pCR Breast | 8.3% | 6.0% | 0% | 21.4% | NS |
pCR Breast + Nodes | 0% | 0% | 0% | 14.3% | NS |
Successful BCS | 75.0% | 72.2% | 63.6% | 57.1% | NS |
RS recurrence score, NHT neoadjuvant hormonal therapy, NCT neoadjuvant chemotherapy, cCR clinical complete response, cPR clinical partial response, pCR pathologic complete response, BCS breast conserving surgery, NS not significant